BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37357760)

  • 21. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 22. Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism.
    Dhingra K; Sahin A; Emami K; Hortobagyi GN; Estrov Z
    Breast Cancer Res Treat; 1998 Mar; 48(2):165-74. PubMed ID: 9596488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant expression of leukemia inhibitory factor receptor (LIFR) and leukemia inhibitory factor (LIF) is associated with tubal pregnancy occurrence.
    Li Y; Sun L; Zhao D; Ouyang J; Xiang M
    Turk J Med Sci; 2015; 45(1):214-20. PubMed ID: 25790555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of LncRNA Lnc-LIF-AS on cell proliferation, migration and invasion in a human cervical cancer cell line.
    Song W; Wang J; Liu H; Zhu C; Xu F; Qian L; Shen Z; Zhu J; Yin S; Qin J; Chen L; Wu D; Nashan B; Shan G; Xiao W; Zhou Y
    Cytokine; 2019 Aug; 120():165-175. PubMed ID: 31085454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of miR-200a-3p with YAP regulates cell proliferation and metastasis differentially in HPV-positive and HPV-negative cervical cancer cells.
    Chen H; Gu L; Zhang M; Chen H; Liao H; Cao X; Yu L; Zhang J
    BMC Cancer; 2022 Oct; 22(1):1039. PubMed ID: 36195847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-589 promotes gastric cancer aggressiveness by a LIFR-PI3K/AKT-c-Jun regulatory feedback loop.
    Zhang F; Li K; Pan M; Li W; Wu J; Li M; Zhao L; Wang H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):152. PubMed ID: 30012200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIF-1
    Abudoukerimu A; Hasimu A; Abudoukerimu A; Tuerxuntuoheti G; Huang Y; Wei J; Yu T; Ma H; Yimiti D
    J Oncol; 2022; 2022():3814809. PubMed ID: 35664561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late gestation modulation of fetal glucocorticoid effects requires the receptor for leukemia inhibitory factor: an observational study.
    Ware CB; Nelson AM; Liggitt D
    Reprod Biol Endocrinol; 2003 May; 1():43. PubMed ID: 12823859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
    Zhao J; Zhang Q; Zou G; Gao G; Yue Q
    J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression.
    Hsu YL; Hung JY; Chou SH; Huang MS; Tsai MJ; Lin YS; Chiang SY; Ho YW; Wu CY; Kuo PL
    Oncogene; 2015 Jul; 34(31):4056-68. PubMed ID: 25381822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation.
    Schiemann WP; Graves LM; Baumann H; Morella KK; Gearing DP; Nielsen MD; Krebs EG; Nathanson NM
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5361-5. PubMed ID: 7777512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer.
    Viswanadhapalli S; Luo Y; Sareddy GR; Santhamma B; Zhou M; Li M; Ma S; Sonavane R; Pratap UP; Altwegg KA; Li X; Chang A; Chávez-Riveros A; Dileep KV; Zhang KYJ; Pan X; Murali R; Bajda M; Raj GV; Brenner AJ; Manthati V; Rao MK; Tekmal RR; Nair HB; Nickisch KJ; Vadlamudi RK
    Mol Cancer Ther; 2019 Aug; 18(8):1341-1354. PubMed ID: 31142661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA-CTD-2108O9.1 represses breast cancer metastasis by influencing leukemia inhibitory factor receptor.
    Wang M; Wang M; Wang Z; Yu X; Song Y; Wang C; Xu Y; Wei F; Zhao Y; Xu Y
    Cancer Sci; 2018 Jun; 109(6):1764-1774. PubMed ID: 29603493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
    Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
    J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
    J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization against leukemia inhibitory factor and its receptor suppresses tumor formation of breast cancer initiating cells in BALB/c mouse.
    Ghanei Z; Mehri N; Jamshidizad A; Joupari MD; Shamsara M
    Sci Rep; 2020 Jul; 10(1):11465. PubMed ID: 32651426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats.
    Suzuki S; Yamashita T; Tanaka K; Hattori H; Sawamoto K; Okano H; Suzuki N
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):685-93. PubMed ID: 15716858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations.
    Kosfeld A; Brand F; Weiss AC; Kreuzer M; Goerk M; Martens H; Schubert S; Schäfer AK; Riehmer V; Hennies I; Bräsen JH; Pape L; Amann K; Krogvold L; Bjerre A; Daniel C; Kispert A; Haffner D; Weber RG
    Hum Mol Genet; 2017 May; 26(9):1716-1731. PubMed ID: 28334964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro.
    Luo J; Chimge NO; Zhou B; Flodby P; Castaldi A; Firth AL; Liu Y; Wang H; Yang C; Marconett CN; Crandall ED; Offringa IA; Frenkel B; Borok Z
    Int J Cancer; 2018 Dec; 143(12):3169-3180. PubMed ID: 30325015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation.
    Song H; Lim H
    Reproduction; 2006 Feb; 131(2):341-9. PubMed ID: 16452727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.